ReP USP - Resultado da busca

Artigo de periodico
Effects of hypoxia and reoxygenation on metabolic profiles of Cardiomyocytes (2024)
Condori, Luis Daniel Montañez; Vivas, Cristofher Victor ; Barreto, Yan Borges ; Gomes, Lígia Ferreira ; Alencar, Adriano Mesquita ; Bloise Júnior, Antonio Carlos
Source: Cell Biochemistry and Biophysics. Unidades: FCF, IF
Subjects: DOENÇAS CARDIOVASCULARES, ANÓXIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONDORI, Luis Daniel Montañez et al. Effects of hypoxia and reoxygenation on metabolic profiles of Cardiomyocytes. Cell Biochemistry and Biophysics, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s12013-024-01249-1. Acesso em: 14 nov. 2024.
APA
Condori, L. D. M., Vivas, C. V., Barreto, Y. B., Gomes, L. F., Alencar, A. M., & Bloise Júnior, A. C. (2024). Effects of hypoxia and reoxygenation on metabolic profiles of Cardiomyocytes. Cell Biochemistry and Biophysics. doi:10.1007/s12013-024-01249-1
NLM
Condori LDM, Vivas CV, Barreto YB, Gomes LF, Alencar AM, Bloise Júnior AC. Effects of hypoxia and reoxygenation on metabolic profiles of Cardiomyocytes [Internet]. Cell Biochemistry and Biophysics. 2024 ;[citado 2024 nov. 14 ] Available from: https://dx.doi.org/10.1007/s12013-024-01249-1
Vancouver
Condori LDM, Vivas CV, Barreto YB, Gomes LF, Alencar AM, Bloise Júnior AC. Effects of hypoxia and reoxygenation on metabolic profiles of Cardiomyocytes [Internet]. Cell Biochemistry and Biophysics. 2024 ;[citado 2024 nov. 14 ] Available from: https://dx.doi.org/10.1007/s12013-024-01249-1
Artigo de periodico
Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease (2022)
Lang, Maria Grabriela; Vinagre, Carmen G C; Bonfa, Eloisa Silva Dutra de Oliveira ; Freitas, Fatima R; Pasoto, Sandra Gofinet ; Brito, Tatiane S; Seguro, Luciana P. C; Maranhão, Raul Cavalcante ; Borba, Eduardo F
Source: Lupus. Unidades: FM, FCF
Subjects: COLESTEROL, LIPOPROTEÍNAS, LÚPUS ERITEMATOSO SISTÊMICO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LANG, Maria Grabriela et al. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease. Lupus, v. 31, n. 6, p. 659-665, 2022Tradução . . Disponível em: https://doi.org/10.1177/09612033221090127. Acesso em: 14 nov. 2024.
APA
Lang, M. G., Vinagre, C. G. C., Bonfa, E. S. D. de O., Freitas, F. R., Pasoto, S. G., Brito, T. S., et al. (2022). Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease. Lupus, 31( 6), 659-665. doi:10.1177/09612033221090127
NLM
Lang MG, Vinagre CGC, Bonfa ESD de O, Freitas FR, Pasoto SG, Brito TS, Seguro LPC, Maranhão RC, Borba EF. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease [Internet]. Lupus. 2022 ; 31( 6): 659-665.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1177/09612033221090127
Vancouver
Lang MG, Vinagre CGC, Bonfa ESD de O, Freitas FR, Pasoto SG, Brito TS, Seguro LPC, Maranhão RC, Borba EF. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease [Internet]. Lupus. 2022 ; 31( 6): 659-665.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1177/09612033221090127
Artigo de periodico
Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: lack of toxicity and therapeutic benefits (2022)
Vital, Carolina Graziani ; Maranhão, Raul Cavalcante ; Freitas, Fatima Rodrigues ; Eyll, Brigitte Marie Van; Graziani, Silvia Regina
Source: Journal of Bone Oncology. Unidade: FCF
Subjects: NANOPARTÍCULAS, NEOPLASIAS ÓSSEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VITAL, Carolina Graziani et al. Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: lack of toxicity and therapeutic benefits. Journal of Bone Oncology, v. 34, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jbo.2022.100431. Acesso em: 14 nov. 2024.
APA
Vital, C. G., Maranhão, R. C., Freitas, F. R., Eyll, B. M. V., & Graziani, S. R. (2022). Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: lack of toxicity and therapeutic benefits. Journal of Bone Oncology, 34, 1-7. doi:10.1016/j.jbo.2022.100431
NLM
Vital CG, Maranhão RC, Freitas FR, Eyll BMV, Graziani SR. Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: lack of toxicity and therapeutic benefits [Internet]. Journal of Bone Oncology. 2022 ;34 1-7.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.jbo.2022.100431
Vancouver
Vital CG, Maranhão RC, Freitas FR, Eyll BMV, Graziani SR. Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: lack of toxicity and therapeutic benefits [Internet]. Journal of Bone Oncology. 2022 ;34 1-7.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.jbo.2022.100431
Artigo de periodico
Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome (2022)
Guido, Maria Carolina ; Lopes, Natalia de Menezes ; Albuquerque, Camila Inagaki ; Tavares, Elaine Rufo ; Jensen, Leonardo; Carvalho, Priscila de Oliveira; Tavoni, Thauany Martins ; Dias, Ricardo Ribeiro; Pereira, Lygia da Veiga ; Laurindo, Francisco Rafael Martins; Maranhão, Raul Cavalcante
Source: Frontiers in Cardiovascular Medicine. Unidades: FM, FCF
Subjects: ADENOSINA, NANOPARTÍCULAS, INFLAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIDO, Maria Carolina et al. Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome. Frontiers in Cardiovascular Medicine, v. 9, p. 1-13 art. 893774, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcvm.2022.893774. Acesso em: 14 nov. 2024.
APA
Guido, M. C., Lopes, N. de M., Albuquerque, C. I., Tavares, E. R., Jensen, L., Carvalho, P. de O., et al. (2022). Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome. Frontiers in Cardiovascular Medicine, 9, 1-13 art. 893774. doi:10.3389/fcvm.2022.893774
NLM
Guido MC, Lopes N de M, Albuquerque CI, Tavares ER, Jensen L, Carvalho P de O, Tavoni TM, Dias RR, Pereira L da V, Laurindo FRM, Maranhão RC. Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome [Internet]. Frontiers in Cardiovascular Medicine. 2022 ; 9 1-13 art. 893774.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/fcvm.2022.893774
Vancouver
Guido MC, Lopes N de M, Albuquerque CI, Tavares ER, Jensen L, Carvalho P de O, Tavoni TM, Dias RR, Pereira L da V, Laurindo FRM, Maranhão RC. Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome [Internet]. Frontiers in Cardiovascular Medicine. 2022 ; 9 1-13 art. 893774.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/fcvm.2022.893774
Artigo de periodico
Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats (2021)
Pepineli, Rafael; Santana, Alexandre Chagas de; Silva, Filipe Miranda de Oliveira; Tavoni, Thauany Martins; Stolf, Noedir Antonio Groppo ; Noronha, Irene de Lourdes ; Maranhão, Raul Cavalcante
Source: Journal of Pharmacy and Pharmacology. Unidades: FM, FCF
Subjects: NANOPARTÍCULAS, LIPÍDEOS, TRANSPLANTE DE ÓRGÃOS, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEPINELI, Rafael et al. Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats. Journal of Pharmacy and Pharmacology, v. 73, p. 1092–1100, 2021Tradução . . Disponível em: https://doi.org/10.1093/jpp/rgab066. Acesso em: 14 nov. 2024.
APA
Pepineli, R., Santana, A. C. de, Silva, F. M. de O., Tavoni, T. M., Stolf, N. A. G., Noronha, I. de L., & Maranhão, R. C. (2021). Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats. Journal of Pharmacy and Pharmacology, 73, 1092–1100. doi:10.1093/jpp/rgab066
NLM
Pepineli R, Santana AC de, Silva FM de O, Tavoni TM, Stolf NAG, Noronha I de L, Maranhão RC. Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats [Internet]. Journal of Pharmacy and Pharmacology. 2021 ; 73 1092–1100.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1093/jpp/rgab066
Vancouver
Pepineli R, Santana AC de, Silva FM de O, Tavoni TM, Stolf NAG, Noronha I de L, Maranhão RC. Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats [Internet]. Journal of Pharmacy and Pharmacology. 2021 ; 73 1092–1100.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1093/jpp/rgab066
Artigo de periodico
Disturbances of the transfer of cholesterol to high-density lipoprotein (HDL) in patients with peripheral artery disease with or without type 2 diabetes mellitus (2021)
Ribeiro, Flávio Roberto Cavalleiro de Macêdo; Ribeiro, Carolina Heitmann Mares Azevedo; Tavoni, Thauany Martins; Sarges, Erica dos Santos; Freitas, Fatima Rodrigues; Stolf, Noedir Antonio Groppo ; Kalil Filho, Roberto ; Maranhão, Raul Cavalcante
Source: Vascular Medicine. Unidades: FM, FCF
Subjects: LIPOPROTEÍNAS HDL, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, DISLIPIDEMIAS, NANOPARTÍCULAS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Flávio Roberto Cavalleiro de Macêdo et al. Disturbances of the transfer of cholesterol to high-density lipoprotein (HDL) in patients with peripheral artery disease with or without type 2 diabetes mellitus. Vascular Medicine, v. 26, n. 6, p. 602–607, 2021Tradução . . Disponível em: https://doi.org/10.1177/1358863X211021142. Acesso em: 14 nov. 2024.
APA
Ribeiro, F. R. C. de M., Ribeiro, C. H. M. A., Tavoni, T. M., Sarges, E. dos S., Freitas, F. R., Stolf, N. A. G., et al. (2021). Disturbances of the transfer of cholesterol to high-density lipoprotein (HDL) in patients with peripheral artery disease with or without type 2 diabetes mellitus. Vascular Medicine, 26( 6), 602–607. doi:10.1177/1358863X211021142
NLM
Ribeiro FRC de M, Ribeiro CHMA, Tavoni TM, Sarges E dos S, Freitas FR, Stolf NAG, Kalil Filho R, Maranhão RC. Disturbances of the transfer of cholesterol to high-density lipoprotein (HDL) in patients with peripheral artery disease with or without type 2 diabetes mellitus [Internet]. Vascular Medicine. 2021 ; 26( 6): 602–607.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1177/1358863X211021142
Vancouver
Ribeiro FRC de M, Ribeiro CHMA, Tavoni TM, Sarges E dos S, Freitas FR, Stolf NAG, Kalil Filho R, Maranhão RC. Disturbances of the transfer of cholesterol to high-density lipoprotein (HDL) in patients with peripheral artery disease with or without type 2 diabetes mellitus [Internet]. Vascular Medicine. 2021 ; 26( 6): 602–607.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1177/1358863X211021142

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title